These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 29486369)
21. Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents. Alanazi AM; Abdel-Aziz AA; Al-Suwaidan IA; Abdel-Hamide SG; Shawer TZ; El-Azab AS Eur J Med Chem; 2014 May; 79():446-54. PubMed ID: 24763265 [TBL] [Abstract][Full Text] [Related]
22. Improving both aqueous solubility and anti-cancer activity by assessing progressive lead optimization libraries. Liu Y; Li F; Wu L; Wang W; Zhu H; Zhang Q; Zhou H; Yan B Bioorg Med Chem Lett; 2015 May; 25(9):1971-5. PubMed ID: 25827524 [TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and biological evaluation of novel 3,4,5-trisubstituted aminothiophenes as inhibitors of p53-MDM2 interaction. Part 2. Wang W; Lv D; Qiu N; Zhang L; Hu C; Hu Y Bioorg Med Chem; 2013 Jun; 21(11):2886-94. PubMed ID: 23611770 [TBL] [Abstract][Full Text] [Related]
24. New C-19-modified geldanamycin derivatives: synthesis, antitumor activities, and physical properties study. Liu YF; Zhong JJ; Lin L; Liu JJ; Wang YG; He WQ; Yang ZY J Asian Nat Prod Res; 2016 Aug; 18(8):752-64. PubMed ID: 26988280 [TBL] [Abstract][Full Text] [Related]
25. Synthesis, in vitro Antiproliferative and Antiinflammatory Activities, and Kinase Inhibitory effects of New 1,3,4-triarylpyrazole Derivatives. El-Gamal MI; Abdel-Maksoud MS; Gamal El-Din MM; Shin JS; Lee KT; Yoo KH; Oh CH Anticancer Agents Med Chem; 2017; 17(1):75-84. PubMed ID: 27334850 [TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and biological evaluation of N-phenylsulfonylnicotinamide derivatives as novel antitumor inhibitors. Zhang H; Lu X; Zhang LR; Liu JJ; Yang XH; Wang XM; Zhu HL Bioorg Med Chem; 2012 Feb; 20(4):1411-6. PubMed ID: 22277588 [TBL] [Abstract][Full Text] [Related]
27. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives. Bakr RB; Mehany ABM; Abdellatif KRA Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084 [TBL] [Abstract][Full Text] [Related]
28. Synthesis of 2,3-di- and 2,2,3-trisubstituted-3-methoxycarbonyl-γ-butyrolactones as potent antitumor agents. Le Floch C; Le Gall E; Sengmany S; Renevret P; Léonel E; Martens T; Cresteil T Eur J Med Chem; 2015 Jan; 89():654-70. PubMed ID: 25462273 [TBL] [Abstract][Full Text] [Related]
29. Optimization of 2-(3-(arylalkyl amino carbonyl) phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents. Wu J; Yu L; Yang F; Li J; Wang P; Zhou W; Qin L; Li Y; Luo J; Yi Z; Liu M; Chen Y Eur J Med Chem; 2014 Jun; 80():340-51. PubMed ID: 24794770 [TBL] [Abstract][Full Text] [Related]
30. Discovery of novel 4-anilinoquinazoline derivatives as potent inhibitors of epidermal growth factor receptor with antitumor activity. Xu YY; Li SN; Yu GJ; Hu QH; Li HQ Bioorg Med Chem; 2013 Oct; 21(19):6084-91. PubMed ID: 23962660 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives. Zheng M; Xu C; Ma J; Sun Y; Du F; Liu H; Lin L; Li C; Ding J; Chen K; Jiang H Bioorg Med Chem; 2007 Feb; 15(4):1815-27. PubMed ID: 17157510 [TBL] [Abstract][Full Text] [Related]
32. Design and synthesis of novel C Lan J; Huang L; Lou H; Chen C; Liu T; Hu S; Yao Y; Song J; Luo J; Liu Y; Xia B; Xia L; Zeng X; Ben-David Y; Pan W Eur J Med Chem; 2018 Jan; 143():1968-1980. PubMed ID: 29133049 [TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and discovery of 5-hydroxyaurone derivatives as growth inhibitors against HUVEC and some cancer cell lines. Cheng H; Zhang L; Liu Y; Chen S; Cheng H; Lu X; Zheng Z; Zhou GC Eur J Med Chem; 2010 Dec; 45(12):5950-7. PubMed ID: 20974505 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and antitumor evaluation of trimethoxyanilides based on 4(3H)-quinazolinone scaffolds. Mohamed MA; Ayyad RR; Shawer TZ; Abdel-Aziz AA; El-Azab AS Eur J Med Chem; 2016 Apr; 112():106-113. PubMed ID: 26890117 [TBL] [Abstract][Full Text] [Related]
35. Facile synthesis of novel substituted aryl-thiazole (SAT) analogs via one-pot multi-component reaction as potent cytotoxic agents against cancer cell lines. Mirza S; Asma Naqvi S; Mohammed Khan K; Salar U; Choudhary MI Bioorg Chem; 2017 Feb; 70():133-143. PubMed ID: 28038777 [TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationship study of syringolin A as a potential anticancer agent. Chiba T; Matsuda A; Ichikawa S Bioorg Med Chem Lett; 2015 Nov; 25(21):4872-4877. PubMed ID: 26231162 [TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and characterization of new embelin derivatives as potent inhibitors of X-linked inhibitor of apoptosis protein. Chen J; Nikolovska-Coleska Z; Wang G; Qiu S; Wang S Bioorg Med Chem Lett; 2006 Nov; 16(22):5805-8. PubMed ID: 16962773 [TBL] [Abstract][Full Text] [Related]
38. Discovery of novel isatin-dehydroepiandrosterone conjugates as potential anticancer agents. Ke S; Shi L; Yang Z Bioorg Med Chem Lett; 2015 Oct; 25(20):4628-31. PubMed ID: 26320625 [TBL] [Abstract][Full Text] [Related]
39. Synthesis and anticancer activities of new 3-allylthio-6-(mono or disubstituted)aminopyridazines. Won YH; Park MS Arch Pharm Res; 2010 Feb; 33(2):189-96. PubMed ID: 20195817 [TBL] [Abstract][Full Text] [Related]
40. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents. Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]